Pfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines.
Pfizer Nears Deal to Combine Off-Patent Drug Business With Mylan - The Wall Street Journal
Read More
Bagikan Berita Ini
Related Posts :
Bund yield hits record low after weak China data and Gulf tension - Financial Times- Man (28) charged in connection with fatal O'Connell Street stabbing - TheJournal.ie
- Tour Anne Frank's childhood home through Google Street View - The Jakarta Post - Jakarta Post
- Bund yield hits record low after weak China data and Gulf tension - Financial Times
- Coronation Street spoilers: Bethany Platt gets a huge shock - Metro.co.uk
0 Response to "Pfizer Nears Deal to Combine Off-Patent Drug Business With Mylan - The Wall Street Journal"
Post a Comment